Aggul AG, Kuzu M, Kandemir FM, Kucukler S, Caglayan C (2020) Alterations in enzyme activity of carbonic anhydrase, 6-phosphogluconate dehydrogenase and thioredoxin reductase in rats exposed to doxorubicin and morin. Clin Exp Health Sci 10:228–234

CAS  Google Scholar 

Akhlaghipour I, Nasimi Shad A, Askari VR, Baradaran Rahimi V (2024) Daidzin and its de-glycosylated constituent daidzein as a potential therapeutic for cardiovascular diseases: a review from bench to bed. Phytother Res PTR 38:3973–3985

Article  PubMed  CAS  Google Scholar 

Al Numair KS, Chandramohan G, Alsaif MA, Baskar AA (2012) Protective effect of morin on cardiac mitochondrial function during isoproterenol-induced myocardial infarction in male Wistar rats. Redox Rep 17:14–21

Article  PubMed  CAS  Google Scholar 

Al-Numair KS, Chandramohan G, Alsaif MA (2012) Pre-treatment with morin, a flavonoid, ameliorates adenosine triphosphatases and glycoproteins in isoproterenol-induced myocardial infarction in rats. J Nat Med 66:95–101

Article  PubMed  CAS  Google Scholar 

Al-Numair KS, Chandramohan G, Alsaif MA, Veeramani C (2014a) Efficacy of morin on serum and heart tissue lipids in rats subjected to isoproterenol-induced myocardial injury. Progress Nutr 16:25–30

Google Scholar 

Al-Numair KS, Chandramohan G, Alsaif MA, Veeramani C, El Newehy AS (2014b) Morin, a flavonoid, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats. Afr J Tradi Compl Altern Med 11:14–20

Article  CAS  Google Scholar 

Aloud AA (2019) Morin controls high-cholesterol diet-induced inflammatory cardiac dysfunction through the regulation of nitric oxide synthesized enzymes and P65 NF-kappa B gene. Progress Nutr 21:793–803

CAS  Google Scholar 

Baradaran Rahimi V, Askari VR (2022) A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β-caryophyllene. BioFactors (Oxford, England) 48:857–882

Article  PubMed  CAS  Google Scholar 

Bartfay WJ, Hou D, Lehotay DC, Bartfay E, Luo X, Liu P (2000) Cardioprotective effects of selenium and morin hydrate in a marine model of chronic iron overload. J Trace Elem Exp Med 13:285–297

Article  CAS  Google Scholar 

Behera SS, Pramanik K, Nayak MK (2015) Recent advancement in the treatment of cardiovascular diseases: conventional therapy to nanotechnology. Curr Pharm Des 21:4479–4497

Article  PubMed  CAS  Google Scholar 

Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR (2010) Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ 88:120–130

Article  PubMed  Google Scholar 

Caselli A, Cirri P, Santi A, Paoli P (2016) Morin: a promising natural drug. Curr Med Chem 23:774–791

Article  PubMed  Google Scholar 

Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS (2012) Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol 60:1207–1216

Article  PubMed  Google Scholar 

Dunbar SB, Khavjou OA, Bakas T, Hunt G, Kirch RA, Leib AR, Morrison RS, Poehler DC, Roger VL, Whitsel LP (2018) Projected costs of informal caregiving for cardiovascular disease: 2015 to 2035: a policy statement from the American Heart Association. Circulation 137:e558–e577

Article  PubMed  Google Scholar 

Fang S-H, Hou Y-C, Chang W-C, Hsiu S-L, Chao P-DL, Chiang B-L (2003) Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci 74:743–756

Article  PubMed  CAS  Google Scholar 

Gong G, Guan Y-Y, Zhang Z-L, Rahman K, Wang S-J, Zhou S, Luan X, Zhang H (2020) Isorhamnetin: a review of pharmacological effects. Biomed Pharmacother 128:110301

Article  PubMed  CAS  Google Scholar 

Hassan NF (2019) Protective role of morin on some parameters related to oxidative stress and metabolic syndrome induced by acrylamide in male rats. Int J Res Pharm Sci 10:331–338

CAS  Google Scholar 

Heeba GH, Rabie EM, Abuzeid MM, Bekhit AA, Khalifa MM (2021) Morin alleviates fructose-induced metabolic syndrome in rats via ameliorating oxidative stress, inflammatory and fibrotic markers. Korean J Physiol Pharmacol 25:177–187

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsia CW, Wu MP, Velusamy M, Hsia CH, Chou DS, Tsai CL, Hsu CY, Jayakumar T, Chung CL, Sheu JR (2018) Novel therapeutic agent against platelet activation in vitro and arterial thrombosis in vivo by morin hydrate. Int J Mol Sci 19:2386

Article  PubMed  PubMed Central  Google Scholar 

James AS, Eteng OE, Dosumu OA, Moses CA, Ogbonna CU, Adeleye OA, Ugwor EI, Omilo BC, Fabunmi RF, Olakitan AM, Ugbaja RN (2023) Morin augmented myocardial eNOS/cGMP/PKG signaling pathway and abated oxidative and inflammo-apoptotic responses in diethyl phthalate and bisphenol-S Co-exposed male Albino rats. Inflammation 46:175–189

Article  PubMed  CAS  Google Scholar 

Kang DG, Moon MK, Sohn EJ, Lee DH, Lee HS (2004) Effects of morin on blood pressure and metabolic changes in fructose-induced hypertensive rats. Biol Pharm Bull 27:1779–1783

Article  PubMed  CAS  Google Scholar 

Kok LD, Wong YP, Wu TW, Chan HC, Kwok TT, Fung KP (2000) Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. Life Sci 67:91–99

Article  PubMed  CAS  Google Scholar 

Kuruvilla A (2002) Herbal formulations as pharmacotherapeutic agents. Indian J Exp Biol 40:7–11

PubMed  CAS  Google Scholar 

Kuzu M, Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Turk E (2018) Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmacother 106:443–453

Article  PubMed  CAS  Google Scholar 

Lee MH, Cha HJ, Choi EO, Han MH, Kim SO, Kim GY, Hong SH, Park C, Moon SK, Jeong SJ (2017) Antioxidant and cytoprotective effects of morin against hydrogen peroxide-induced oxidative stress are associated with the induction of Nrf-2-mediated HO-1 expression in V79–4 Chinese hamster lung fibroblasts. Int J Mol Med 39:672–680

Article  PubMed  CAS  Google Scholar 

Lian TW, Wang L, Lo YH, Huang IJ, Wu MJ (2008) Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochim Biophys Acta 1781:601–609

Article  PubMed  CAS  Google Scholar 

Liu S, Wu N, Miao J, Huang Z, Li X, Jia P, Guo Y, Jia D (2018) Protective effect of morin on myocardial ischemia-reperfusion injury in rats. Int J Mol Med 42:1379–1390

PubMed  PubMed Central  CAS  Google Scholar 

López-Tenorio II, Domínguez-López A, Miliar-García Á, Escalona-Cardoso GN, Real-Sandoval SA, Gómez-Alcalá A, Jaramillo-Flores ME (2020) Modulation of the mRNA of the Nlrp3 inflammasome by Morin and PUFAs in an obesity model induced by a high-fat diet. Food Res Int 137:109706

Article  PubMed  Google Scholar 

Madkhali HA (2020) Morin attenuates high-fat diet induced-obesity related vascular endothelial dysfunction in Wistar albino rats. Saudi Pharm J 28:300–307

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meng Q, Pu L, Lu Q, Wang B, Li S, Liu B, Li F (2021) Morin hydrate inhibits atherosclerosis and LPS-induced endothelial cells inflammatory responses by modulating the NFκB signaling-mediated autophagy. Int Immunopharmacol 100:108096

Article  PubMed  CAS  Google Scholar 

Nam GS, Lee KS, Nam KS (2019) Morin hydrate inhibits platelet activation and clot retraction by regulating integrin alpha(IIb)beta(3), TXA(2), and cAMP levels. Eur J Pharmacol 865:172734

Article  PubMed  CAS  Google Scholar 

Nasimi Shad A, Akhlaghipour I, Babazadeh Baghan A, Askari VR, Baradaran Rahimi V (2024) Caffeic acid and its derivative caffeic acid phenethyl ester as potential therapeutic compounds for cardiovascular diseases: a systematic review. Arch Pharm (Weinheim) 357:e2400240

Article  PubMed  CAS  Google Scholar